"The cancer bond": exploring the formation of cancer risk perception in families with Lynch syndrome.
This study explores the social context of hereditary cancer risk perception in three families, an African-American family, a Mexican-American family, and a Caucasian family, each with Lynch Syndrome documented by a mismatch repair gene mutation. Communication network assessments measured family communication about cancer experiences and genetic testing information among a total of 26 participants. Participant narratives were evaluated to gain insight into how family cancer experiences and genetic testing information have shaped perceptions of cancer risk. Analysis of communication networks indicated that some families discussed cancer experiences to a greater extent than genetic testing information, and vice-versa. Interviews elucidated that sharing both types of health information led participants to conceptualize linkages among a strong family history of cancer, genetic testing information, and cancer prevention strategies. Understanding how different types of family communication influence the formation of perceived hereditary disease risk may enhance efforts to tailor genetic counseling services for families.
Palmquist
Aunchalee E L
AE
Social and Behavioral Research Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA. aunchalee.palmquist@yale.edu
Koehly
Laura M
LM
Peterson
Susan K
SK
Shegog
Margarette
M
Vernon
Sally W
SW
Gritz
Ellen R
ER
D003123:Colorectal Neoplasms, Hereditary Nonpolyposis / Q000235:genetics / Q000523:psychology*; D003430:Cross-Sectional Studies; D005190:Family / Q000523:psychology*; D005817:Genetic Counseling; D005820:Genetic Testing; D006801:Humans; D012307:Risk Factors
Cancer Epidemiol Biomarkers Prev. 1999 Apr;8(4 Pt 2):353-60
10207640
N Engl J Med. 2003 Mar 6;348(10):919-32
12621137
Clin Genet. 2003 Sep;64(3):179-89
12919131
Cancer Epidemiol Biomarkers Prev. 2003 Apr;12(4):304-13
12692104
Am J Med Genet C Semin Med Genet. 2003 May 15;119C(1):78-86
12704641
Sch Inq Nurs Pract. 1994 Spring;8(1):5-142
7938979
CA Cancer J Clin. 2002 Jan-Feb;52(1):23-47
11814064
J Natl Med Assoc. 2007 Oct;99(10):1105-12
17987913
Psychooncology. 2009 Nov;18(11):1208-15
19177338
Clin Genet. 2009 Jul;76(1):1-18
19659756
Cancer. 2009 Sep 15;115(18):4071-9
19536903
Am J Public Health. 2009 Dec;99(12):2203-9
19833996
J Natl Med Assoc. 2004 May;96(5):598-608
15160974
Community Genet. 2008;11(5):283-8
18493126
Health Psychol. 1997 Jan;16(1):73-86
9028817
JAMA. 2006 Sep 27;296(12):1507-17
17003399
Cancer Treat Rev. 2003 Dec;29(6):461-70
14585257
Am J Med Genet A. 2004 Jul 30;128A(3):261-70
15216547
Community Genet. 2003;6(1):29-36
12748436
Bull Cancer. 2004 Apr;91(4):303-15
15242312
CA Cancer J Clin. 2002 May-Jun;52(3):134-49
12018928
Curr Opin Psychiatry. 2009 Mar;22(2):218-23
19553879
Genet Med. 2009 Oct;11(10):728-34
19707152
J Genet Couns. 2009 Jun;18(3):252-64
19294336
J Natl Med Assoc. 2000 Oct;92(10):492-500
11105730
Eur J Hum Genet. 2009 Jul;17(7):872-80
19319160
J Genet Couns. 2005 Apr;14(2):133-40
15959644
J Clin Oncol. 2004 Dec 15;22(24):4934-43
15611508
Genet Test. 2005 Fall;9(3):261-8
16225406
J Clin Oncol. 2005 Mar 20;23(9):1902-10
15774782
Genet Med. 2007 May;9(5):275-82
17505204